HDFC Securities projected that India s GDP is likely to soar, from $3.57 tn in FY24E to $7 tn by 2030. The nation is witnessing decade-long economic trends that are propelling the expansion of businesses across diverse sectors. Let s take a look at these trends and stocks that will be impacted.
Analysts of IIFL Securities replace BAF with Chola Investment in their large-cap picks, along with removing Trent and Mankind after their recent OP, and retain their overall constructive stance. Geo-politics causing a sharp crude spike is a risk.
"Nifty formed a bearish candle with a substantial body in the daily chart. The Donchian Channels, which identify bullish and bearish extremes, indicate that Nifty is holding its middle band. Key support levels are identified at 21,400, while resistance is placed at 21,700 levels," said Om Mehra, Technical Analyst, SAMCO Securities.
Investec maintained a buy rating on Orchid Pharma with a target price of Rs 800. The company is set for strong growth over the next 3 years. The new management continues to execute the turnaround strategy well. It sees a strong 35%+ EBITDA CAGR over FY23-26 for the base biz (ex-PLI).